# Trade Mark Journal No.2026/022 29 May 2026

## WO0000001917405 (9,44)

Office of origin: Canada

Date of International Registration:10 March 2026
Date of designation in the UK: 10 March 2026

International priority date claimed: 11 September 2025 (Canada) (2423690)

Class 9
  Computer software for medical imaging; downloadable and recorded computer software for medical diagnostic imaging for use in diagnosis and treatment of bowel inflammatory diseases and conditions; recorded and downloadable computer software for monitoring and managing patient medical records; clinical decision support software and application; software as a medical device [SaMD], downloadable, for processing and analysis of ultrasound images for medical diagnostic imaging; computer software for monitoring patient medical information computer software for monitoring patient medical information; computer software for use in testing, monitoring, research, analysis and assessment of inflammatory bowel diseases for medical purposes and for purposes of conducting clinical trials; downloadable web application software for use in search and reference of medical conditions for medical diagnostic services; computer software featuring artificial intelligence for use with pattern discovery, recognition, classification, segmentation and visualization of medical data.
Class 44
  Providing medical information and advice in the field of inflammatory bowel disease and gastroenterology; providing information concerning the use of medical diagnostic imaging equipment by means of a web site; information, advisory and consultancy services in the field of prevention and treatment of gastro-intestinal disorders; information, advisory and consultancy services in the field of medical care, analysis services and medical treatment services; providing information for patients and healthcare professionals in the field of gastro-intestinal disorders via a website; medical imaging services and medical screening; medical and health care services in the field of gastro-intestinal disorders; bowel cancer screening services; medical care and analysis services relating to patient treatment; medical clinic services; medical analysis services for the diagnosis of inflammatory bowel diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services for inflammatory bowel diseases diagnosis and prognosis; consulting and services provider for providing medical information in the field of artificial intelligence based medical devices for pattern discovery, recognition, classification, segmentation, and visualization of medical data; consulting and services provider for providing medical information in the field of software products for pattern discovery, recognition, classification, segmentation, and visualization of medical data.

Dova Health Intelligence Inc.

Representative: MLT AIKINS LLP, 2100 Livingston Place, 222-3rd Avenue SW, Calgary AB T2P 0B4, CANADA